Abraxis Bioscience, LLC – FDA 483, Feb 19, 2020
Abraxis Bioscience, LLC, a sterile drug manufacturer in Phoenix, AZ, received a Form 483 with four observations related to significant quality system deficiencies. The inspection revealed issues with personnel training for aseptic processes, inadequate computer system controls allowing unauthorized data manipulation, incomplete investigation records for deviations and CAPAs, and widespread failures in good documentation practices including late entries and unrecorded deviations. These findings indicate a need for comprehensive improvements in the firm's quality management system.
- Office
- Denver District Office
- Person
ID · 56322b10-4097-43ef-b961-9927ed0e18e9
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.